Skip to search formSkip to main contentSkip to account menu

norelgestromin

Known as: 17-deacetylnorgestimate, norelgestromin [Chemical/Ingredient], Norplant 3-oxime 
National Institutes of Health

Related topics

Related topics

17 relations
AmenorrheaDrug AllergyEthinyl Estradiol / norelgestrominLiver diseases

Broader (5)

Combined Oral ContraceptivesNorgestrelNorplantOximes

Narrower (2)

Ortho EvraXulane

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Comparison of a transdermal contraceptive patch with a newly sourced adhesive component versus EVRA patch: A double-blind, randomized, bioequivalence and adhesion study in healthy women.
2015
2015
A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study.
Review
2013
Review
2013
Skin patch and vaginal ring versus combined oral contraceptives for contraception.
BACKGROUND The delivery of combination contraceptive steroids from a transdermal contraceptive patch or a contraceptive vaginal… 
2010
2010
Iontophoretic Transdermal Drug Delivery
2008
2008
Pharmacological profile of progestins.
The synthetic progestins used so far for contraception and menopausal hormone therapy are derived either from testosterone (19… 
2007
2007
Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line
Background. Acne occurs from an overstimulation of the sebaceous glands by high levels of androgens or because sebaceous glands… 
Review
2005
Review
2005
Norelgestromin/ethinyl estradiol transdermal system.
The transdermal contraceptive patch is an innovative contraceptive technology. The failure rate is quite low and has high… 
2003
2003
Transdermal Ethinylestradiol/Norelgestromin
En]SummaryAbstractEthinylestradiol 20 μg/day plus norelgestromin 150 μg/day have been formulated into a transdermal patch for… 
2001
2001
Pharmacokinetics of Norelgestromin and Ethinyl Estradiol from Two Consecutive Contraceptive Patches
The primary objective of this open‐label study was to determine the pharmacokinetics of norelgestromin (NGMN) and ethinyl… 
1999
1999
Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)